QARS Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-QARS antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | QARS |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | antigen affinity purified |
| Size | 0.02 mL, 0.06 mL, 0.12 mL |
| Concentration | 0.84mg/mL |
| Applications | Immunohistochemistry (IHC), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. In metazoans, 9 aminoacyl-tRNA synthetases specific for glutamine (gln), glutamic acid (glu), and 7 other amino acids are associated within a multienzyme complex. Although present in eukaryotes, glutaminyl-tRNA synthetase (QARS) is absent from many prokaryotes, mitochondria, and chloroplasts, in which Gln-tRNA(Gln) is formed by transamidation of the misacylated Glu-tRNA(Gln). Glutaminyl-tRNA synthetase belongs to the class-I aminoacyl-tRNA synthetase family. |
| Immunogen | Immunogen: Fusion protein of human QARS |
| Other Names | [GlnRS; Glutamine tRNA ligase; Glutamine tRNA synthetase; Glutamine--tRNA ligase; Glutaminyl tRNA ligase; Glutaminyl tRNA synthetase; Glutaminyl-tRNA synthetase; PRO2195; QARS; SYQ] |
| Gene, Accession # | [QARS], Gene ID: 5859, NCBI: NP_005042, UniProt: P47897 |
| Catalog # | MBS2560626 |
| Price | $110, $150, $225 |
| Order / More Info | QARS Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies